of cash inflow from sales and services, offsetting with cash outflow for expenses and income tax payment Cash inflow from financing activities Baht 1,820 million consisted of proceed of short-term
the expiration of corporate income tax exemption privilege from BOI since April 2019, resulting in 1.80 million baht increase in tax expenses from the same period last year. Furthermore, the
2019 (COVID-19) has caused a widespread economic slowdown which affects many businesses and industries, especially events. Therefore, revenues from the Company’ s major businesses were affected. Income
2.65 million and increase in deferred income tax of Baht 1.99 million but there were a net decrease in inventory of Baht 82.54 million, decrease in cash advance payment for purchase of assets of Baht
of corporate income tax exemption privilege from BOI since April 2019, resulting in 0.75 million baht increase in tax expenses in the 3-month period ended 31 March 2020 compared to the same period last
ไดส้ าหรบัไตรมาส 2 ปี 2563 จ านวน (4.83)ลา้นบาท เกิดจากการปรบัปรุงประมาณการภาษีเงินได้ และภาษีเงินไดร้อการตดับญัชี (Deferred Income Tax) 6. ก ำไรสุทธิ บริษัทมีขาดทุนสุทธิ ส าหรบัไตรมาส 2 ปี 2563 เท่ากับ
Group was able to grow continuously revenue from rent and service business, which was recurring income, despite the negative impact on both economic and the COVID-19 pandemic. Revenue from rent and
% -20.4% Cost of rental and rendering of services 1/ 72.1 75.3 73.3 +1.6% -2.7% Cost of sales and services 1,363.9 1,485.6 1,195.8 -12.3% -19.5% Gross profit 1,062.1 1,070.6 1,015.3 -4.4% -5.2% Other income
. Earnings before Interest, Corporate Income Tax, Depreciation and Amortization (EBITDA) In 1Q20, the Company’s EBITDA was Baht 241 million increased by 8.6% YoY as a result of the increase in EBITDA in Food
with the same period of last year. The income statement in brief is presented as following: DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000